drugset / Trial / NCT02133989
Clopidogrel Resistance and Embolism in Carotid Artery Stenting
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of the ticlopidine + ginko biloba compared to clopidogrel in clopidogrel resistant patients undergoing carotid artery stent placement. The investigators hypothesized that ticlopidine + ginko biloba is superior than clopidogrel in terms of post-stent ischemic lesions in these patients without serious complications.
Timeline
- Start
- 2014-06
- Primary completion
- 2017-12
- Completion
- 2017-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Clopidogrel | Small molecule | 97.875 mg | — |
| Subject | Ginko Biloba | Unknown | 80 mg | — |
| Subject | ticlopidine | Small molecule | 250 mg | — |